HomeBALAXI • NSE
add
Balaxi Pharmaceuticals Ltd
Previous close
₹28.71
Day range
₹28.51 - ₹29.26
Year range
₹28.41 - ₹84.00
Market cap
1.59B INR
Avg Volume
157.70K
P/E ratio
11.06
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 561.75M | -27.41% |
Operating expense | 264.62M | 14.61% |
Net income | 2.09M | -95.45% |
Net profit margin | 0.37 | -93.76% |
Earnings per share | — | — |
EBITDA | 11.58M | -89.08% |
Effective tax rate | 84.82% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 388.49M | -36.17% |
Total assets | 3.22B | 11.98% |
Total liabilities | 844.30M | 17.11% |
Total equity | 2.38B | — |
Shares outstanding | 52.25M | — |
Price to book | 0.63 | — |
Return on assets | — | — |
Return on capital | 0.59% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 2.09M | -95.45% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1942
Website
Employees
600
